RET and neuroblastoma: RET inhibition has been found to be effective in in vitro and in vivo preclinical models of neuroblastoma [109,110,111], and a recently opened clinical trial (NCT03611595) will evaluate the efficacy of the combination of RET inhibition and retinoid therapy in children with neuroblastoma and other solid tumors.